Back
Actuate Therapeutics, Inc. Stock Price Chart
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
51
ACTU
Actuate Therapeutics, Inc.
Last Price:
$7.34
Seasonality Move:
-23.17%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACTU is experiencing selling pressure, which indicates risk of future bearish movement.
Actuate Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.18 | Buy |
| 20-day SMA: | 6.51 | Buy |
| 50-day SMA: | 6.87 | Buy |
| 200-day SMA: | 7.62 | Sell |
| 8-day EMA: | 7.14 | Buy |
| 20-day EMA: | 6.83 | Buy |
| 50-day EMA: | 6.88 | Buy |
| 200-day EMA: | 7.44 | Sell |
Actuate Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 60.12 | Buy |
| Chaikin Money Flow: | -40090 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.96 - 7.06) | Buy |
| Bollinger Bands (100): | (6.4 - 7.96) | Buy |
Actuate Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Actuate Therapeutics, Inc. Stock
Is Actuate Therapeutics, Inc. Stock a Buy?
-
Actuate Therapeutics, Inc. share price is 7.35 while ACTU 8-day simple moving average is 7.18, which is a Buy signal.
-
The stock price of ACTU is 7.35 while Actuate Therapeutics, Inc. 20-day SMA is 6.51, which makes it a Buy.
-
Actuate Therapeutics, Inc. 50-day simple moving average is 6.87 while ACTU share price is 7.35, making it a Buy technically.
-
ACTU stock price is 7.35 and Actuate Therapeutics, Inc. 200-day simple moving average is 7.62, creating a Sell signal.
ACTU Technical Analysis vs Fundamental Analysis
Buy
51
Actuate Therapeutics, Inc. (ACTU)
is a Buy
Is Actuate Therapeutics, Inc. a Buy or a Sell?
-
Actuate Therapeutics, Inc. stock is rated a BuyThe current Actuate Therapeutics, Inc. [ACTU] share price is $7.35. The Score for ACTU is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Actuate Therapeutics, Inc. Stock Info
Market Cap:
170.8M
Price in USD:
7.35
Share Volume:
57.1K
Actuate Therapeutics, Inc. 52-Week Range
52-Week High:
11.99
52-Week Low:
5.47
Buy
51
Actuate Therapeutics, Inc. (ACTU)
is a Buy
Actuate Therapeutics, Inc. Share Price Forecast
-
What is the Actuate Therapeutics, Inc. stock price today?The Actuate Therapeutics, Inc. stock price is 7.35 USD today.
-
Will ACTU stock go up or go down?Actuate Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Actuate Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Actuate Therapeutics, Inc. is not overvalued.
Is Actuate Therapeutics, Inc. Stock a Buy?
-
Actuate Therapeutics, Inc. share price is 7.35 while ACTU 8-day exponential moving average is 7.14, which is a Buy signal.
-
The stock price of ACTU is 7.35 while Actuate Therapeutics, Inc. 20-day EMA is 6.83, which makes it a Buy.
-
Actuate Therapeutics, Inc. 50-day exponential moving average is 6.88 while ACTU share price is 7.35, making it a Buy technically.
-
ACTU stock price is 7.35 and Actuate Therapeutics, Inc. 200-day simple moving average is 7.44, creating a Sell signal.
Fundamental Analysis of Actuate Therapeutics, Inc.
Is Actuate Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.08 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Actuate Therapeutics, Inc.
Should I short Actuate Therapeutics, Inc. stock?
-
ACTU Moving Average Covergence Divergence (MACD) indicator is 0.18, suggesting Actuate Therapeutics, Inc. is a Buy
-
Actuate Therapeutics, Inc. Relative Strength Index (RSI) is 60.12, which suggest Actuate Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Actuate Therapeutics, Inc. is (5.96 - 7.06), which suggest Actuate Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Actuate Therapeutics, Inc. is (6.4 - 7.96), which suggest Actuate Therapeutics, Inc. is a Buy
* Actuate Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.